KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Payout Ratio (2016 - 2025)

Pfizer (PFE) has disclosed FCF Payout Ratio for 17 consecutive years, with 0.54 as the latest value for Q4 2025.

  • On a quarterly basis, FCF Payout Ratio rose 32.41% to 0.54 in Q4 2025 year-over-year; TTM through Dec 2025 was 1.08, a 11.33% increase, with the full-year FY2025 number at 1.08, up 11.33% from a year prior.
  • FCF Payout Ratio was 0.54 for Q4 2025 at Pfizer, down from 0.61 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 31.55 in Q2 2023 to a low of 2.04 in Q2 2025.
  • A 5-year average of 2.24 and a median of 0.4 in 2024 define the central range for FCF Payout Ratio.
  • Biggest YoY gain for FCF Payout Ratio was 8173.45% in 2023; the steepest drop was 460.69% in 2023.
  • Pfizer's FCF Payout Ratio stood at 0.26 in 2021, then surged by 39.36% to 0.37 in 2022, then skyrocketed by 51.07% to 0.55 in 2023, then fell by 25.68% to 0.41 in 2024, then soared by 32.41% to 0.54 in 2025.
  • Per Business Quant, the three most recent readings for PFE's FCF Payout Ratio are 0.54 (Q4 2025), 0.61 (Q3 2025), and 2.04 (Q2 2025).